Correlation of bioactive components of platelet rich plasma derived from human female adult peripheral blood and umbilical cord blood with age

Sci Rep. 2023 Oct 27;13(1):18428. doi: 10.1038/s41598-023-45747-3.

Abstract

Platelet-rich plasma (PRP) has gained significant attention in the field of regenerative medicine due to its potential therapeutic applications. However, few studies have reported the components, especially anti-ageing-related components, of PRP derived from umbilical cord blood (UCB). It is essential to understand the influence of age on the composition and efficacy of PRP to optimize its clinical use. The present study compared the concentrations of bioactive components in PRP from healthy female adults and UCB-derived PRP. PRP was obtained from blood samples from females in four age groups (12 per group): neonates (UCB donors) and adults aged 18-25, 26-45, and 46-65 years, respectively. The concentrations of epidermal growth factor, basic fibroblast growth factor-2 (FGF-2), insulin-like growth factor-1, platelet-derived growth factor-AA (PDGF-AA), PDGF-AB/BB, vascular endothelial growth factor A, RANTES, TIMP-1, TIMP-2, GDF11, and clusterin and activity of superoxide dismutase, catalase, and glutathione peroxidase (GPx) in the PRP samples were determined and compared among groups. Pairwise comparisons between the groups showed statistically significant differences in the concentrations of some bioactive components of PRP, such as FGF-2, PDGF-AB/BB, and clusterin, and GPx activity. UCB-derived PRP contains various active ingredients such as VEGF-A, CAT activity, and TIMP-2. Contrary to expectations, UCB-derived PRP did not show higher concentrations of the anti-ageing protein GDF11. Because UCB is a rich source of bioactive components with low immunogenicity, its use in PRP preparation is an important research direction for future studies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Becaplermin
  • Bone Morphogenetic Proteins
  • Clusterin
  • Female
  • Fetal Blood
  • Fibroblast Growth Factor 2
  • Growth Differentiation Factors
  • Humans
  • Infant, Newborn
  • Platelet-Rich Plasma*
  • Tissue Inhibitor of Metalloproteinase-2
  • Vascular Endothelial Growth Factor A*
  • Young Adult

Substances

  • Vascular Endothelial Growth Factor A
  • Clusterin
  • Tissue Inhibitor of Metalloproteinase-2
  • Fibroblast Growth Factor 2
  • Becaplermin
  • GDF11 protein, human
  • Bone Morphogenetic Proteins
  • Growth Differentiation Factors